Allison Wills 2021-04-20 Allison Wills 2021-04-20 Frameworks for Outcomes-Based Agreements 16-03 Read More Allison Wills 2021-04-19 Allison Wills 2021-04-19 Data for Outcomes-Based Agreements 16-04 Read More Allison Wills 2021-04-18 Allison Wills 2021-04-18 Dr. Luca Pani: The Italian OBA Connection 16-05 Read More Allison Wills 2021-01-21 Allison Wills 2021-01-21 By the Numbers: Originator Biologics and Biosimilars Come Out on Top 15-01 Read More Allison Wills 2021-01-20 Allison Wills 2021-01-20 Tug of War: Biosimilars And Biologics Have Yet to Settle into Harmonious Coexistence 15-02 Read More Allison Wills 2021-01-19 Allison Wills 2021-01-19 Biosimilar Breakthrough: Alan Low on the Impact of B.C.’s Biosimilar Policies 15-03 Read More Allison Wills 2020-10-17 Allison Wills 2020-10-17 Using patient data to improve patient care: Are we there yet? 14-01 Read More Allison Wills 2020-10-16 Allison Wills 2020-10-16 Patients, projects, and data points: Eva Villalba connects the dots 14-02 Read More Allison Wills 2020-10-15 Allison Wills 2020-10-15 Handle with care: Lisa Machado on the wise use of patient data 14-03 Read More Allison Wills 2020-10-14 Allison Wills 2020-10-14 Patient-centred initiatives you need to know about 14-04 Read More Allison Wills 2020-07-23 Allison Wills 2020-07-23 How specialty pharma shifted gears during the pandemic – and what will change forever 13-01 Read More Allison Wills 2020-07-22 Allison Wills 2020-07-22 Putting patients first: How seven specialty medicine stakeholders rose to the Covid challenge 13-02 Read More Allison Wills 2020-07-21 Allison Wills 2020-07-21 Connecting the dots along the supply chain: Interview with Catherine Coles 13-03 Read More Allison Wills 2020-04-21 Allison Wills 2020-04-21 Big data and specialty drugs: A high-traffic intersection 12-01 Read More Allison Wills 2020-04-20 Allison Wills 2020-04-20 Q&A: At the epicentre of real-world data: a conversation with Winson Cheung 12-02 Read More Allison Wills 2020-04-19 Allison Wills 2020-04-19 Around the bend: What’s coming and why it matters 12-03 Read More Allison Wills 2020-01-23 Allison Wills 2020-01-23 Tremors in PSP land 11-01 Read More Allison Wills 2020-01-22 Allison Wills 2020-01-22 One PSP challenge, four big ideas 11-02 Read More Allison Wills 2020-01-21 Allison Wills 2020-01-21 Insights of a PSP strategist: an interview with Andrea de Jaray 11-03 Read More Allison Wills 2020-01-20 Allison Wills 2020-01-20 Checking in on the levels: Where are Canada’s PSPs today? 11-04 Read More Newer Posts Older Posts
Allison Wills 2021-04-20 Allison Wills 2021-04-20 Frameworks for Outcomes-Based Agreements 16-03 Read More
Allison Wills 2021-04-18 Allison Wills 2021-04-18 Dr. Luca Pani: The Italian OBA Connection 16-05 Read More
Allison Wills 2021-01-21 Allison Wills 2021-01-21 By the Numbers: Originator Biologics and Biosimilars Come Out on Top 15-01 Read More
Allison Wills 2021-01-20 Allison Wills 2021-01-20 Tug of War: Biosimilars And Biologics Have Yet to Settle into Harmonious Coexistence 15-02 Read More
Allison Wills 2021-01-19 Allison Wills 2021-01-19 Biosimilar Breakthrough: Alan Low on the Impact of B.C.’s Biosimilar Policies 15-03 Read More
Allison Wills 2020-10-17 Allison Wills 2020-10-17 Using patient data to improve patient care: Are we there yet? 14-01 Read More
Allison Wills 2020-10-16 Allison Wills 2020-10-16 Patients, projects, and data points: Eva Villalba connects the dots 14-02 Read More
Allison Wills 2020-10-15 Allison Wills 2020-10-15 Handle with care: Lisa Machado on the wise use of patient data 14-03 Read More
Allison Wills 2020-10-14 Allison Wills 2020-10-14 Patient-centred initiatives you need to know about 14-04 Read More
Allison Wills 2020-07-23 Allison Wills 2020-07-23 How specialty pharma shifted gears during the pandemic – and what will change forever 13-01 Read More
Allison Wills 2020-07-22 Allison Wills 2020-07-22 Putting patients first: How seven specialty medicine stakeholders rose to the Covid challenge 13-02 Read More
Allison Wills 2020-07-21 Allison Wills 2020-07-21 Connecting the dots along the supply chain: Interview with Catherine Coles 13-03 Read More
Allison Wills 2020-04-21 Allison Wills 2020-04-21 Big data and specialty drugs: A high-traffic intersection 12-01 Read More
Allison Wills 2020-04-20 Allison Wills 2020-04-20 Q&A: At the epicentre of real-world data: a conversation with Winson Cheung 12-02 Read More
Allison Wills 2020-04-19 Allison Wills 2020-04-19 Around the bend: What’s coming and why it matters 12-03 Read More
Allison Wills 2020-01-21 Allison Wills 2020-01-21 Insights of a PSP strategist: an interview with Andrea de Jaray 11-03 Read More
Allison Wills 2020-01-20 Allison Wills 2020-01-20 Checking in on the levels: Where are Canada’s PSPs today? 11-04 Read More
